As of 2024-12-12, the Fair Value of Xphyto Therapeutics Corp (XPHY.CN) is -1.10 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.50 CAD, the upside of Xphyto Therapeutics Corp is -321.48%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -20.64 | -12.38 | - | - | -16.51 | |
| YoY growth | -22.19% | 40.03% | - | - | 8.92% | |
| Market Cap (mil) | 49.85 |
| P/E | |
| Forward P/E |
| EPS | -0.12 |
| Avg earnings growth rate | 8.92% |
| TTM earnings | -12.38 |